Also trades as: TRSSF (OTC) · $vol 0M · TER.CN (CNQ) · $vol 0M · TSND.TO (TSX) · $vol 0M

$0.52

-0.01 (-2.26%)

Weekly Expected Move ±12.3%

$0 $0 $1 $1 $1

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 37 · $193.0M mcap · 221M float · 0.121% daily turnover · Short 23% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Income Trends

Revenue

$261M -40.9% ▼

Gross Profit

$136M -36.8% ▼

Operating Income

$42M +270.8% ▲

Net Income

-$86M -7.5% ▼

EPS (Diluted)

$-0.40 -42.9% ▼

EBITDA

$86M +73.8% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2025
Revenue	$261M
YoY Growth	-40.9%
Cost of Revenue	$124M
Gross Profit	$136M
Gross Margin	52.3%
R&D Expenses	$0
SG&A Expenses	$86M
Operating Expenses	$94M
Operating Income	$42M
Operating Margin	16.1%
Interest Expense	$51M
Income Before Tax	$5M
Tax Expense	$29M
Net Income	-$86M
Net Margin	-33.1%
EPS (Diluted)	$-0.40
EBITDA	$86M
Shares Outstanding	301M

Line Item	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$65M	$59M	$66M	$65M
Cost of Revenue	$31M	$27M	$31M	$31M
Gross Profit	$34M	$32M	$35M	$34M
Gross Margin	52.1%	54.4%	52.8%	52.1%
R&D Expenses	$0	$0	$0	$0
SG&A Expenses	$21M	$28M	$21M	$22M
Operating Expenses	$23M	$21M	$23M	$22M
Operating Income	$11M	$10M	$12M	$12M
Operating Margin	17.1%	17.5%	17.6%	18.0%
Interest Expense	$9M	$24M	$10M	$9M
Income Before Tax	$1M	-$2M	$3M	$1M
Tax Expense	$11M	-$2M	$10M	$11M
Net Income	-$26M	$2M	-$9M	-$9M
Net Margin	-39.6%	4.2%	-13.8%	-13.6%
EPS (Diluted)	$-0.12	$0.01	$-0.03	$-0.03
EBITDA	$3M	$20M	$16M	$16M
Shares Outstanding	306M	301M	309M	309M

TSNDF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet